Cadrenal Therapeutics (CVKD) Interest Coverage Ratio (2022 - 2026)
Cadrenal Therapeutics (CVKD) posted Interest Coverage Ratio of 7.52 for Q3 2024, up 97.28% sequentially from 276.28 in Q2 2024, and down 387.3% YoY from 2.62 in Q4 2023.
Cadrenal Therapeutics (CVKD) Interest Coverage Ratio (2022 - 2026) Analysis & Trends
Cadrenal Therapeutics has reported Interest Coverage Ratio for 3 years, with the latest figure at 7.52 in Q3 2024.
- Quarterly Interest Coverage Ratio fell 387.3% year-over-year to 7.52 in Q3 2024, while the trailing twelve-month figure through Sep 2024 was 24.3 (down 141.57% YoY) and the FY2023 annual result came in at 3.5, up 37.95% from the prior year.
- Interest Coverage Ratio rose to 7.52 in Q3 2024 per CVKD's latest filing, from 276.28 in the prior quarter.
- Over five years, Interest Coverage Ratio peaked at 1.03 in Q2 2023 and troughed at 3850.03 in Q1 2024.
- A 3-year average of 442.96 and a median of 65.63 in 2022 frame the typical range for Interest Coverage Ratio.
- The sharpest annual moves came in 2023 and 2024: Interest Coverage Ratio jumped 98.63% in 2023, then plunged 74008.92% in 2024.
- Over 3 years, Interest Coverage Ratio stood at 59.43 in 2022, then soared by 97.4% to 1.54 in 2023, then tumbled by 387.3% to 7.52 in 2024.
- According to Business Quant data, Interest Coverage Ratio over the past three periods registered 7.52, 276.28, and 3850.03 for Q3 2024, Q2 2024, and Q1 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.66 Bn | 131.80 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.52 Bn | 78.53 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 65.33 Bn | 60.14 Bn | 1.37 Bn | - |
| 4 | Moderna | 59.76 Bn | 54.62 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 42.15 Bn | 37.05 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 31.84 Bn | 28.53 Bn | 992.69 Mn | 2.82 |
| 7 | BioNTech SE | 28.23 Bn | 9.84 Bn | 668.28 Mn | 76.86 |
| 8 | Insmed | 27.52 Bn | 26.36 Bn | 358.27 Mn | -0.08 |
| 9 | Royalty Pharma | 27.29 Bn | 26.46 Bn | - | 1.42 |
| 10 | Cadrenal Therapeutics | 4.66 Mn | 2.26 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -356.31 |
| Jun 30, 2025 | -19.57 |
| Sep 30, 2024 | -7.52 |
| Jun 30, 2024 | -276.28 |
| Mar 31, 2024 | -3,850.03 |
| Sep 30, 2023 | -1.54 |
| Jun 30, 2023 | -1.03 |
| Mar 31, 2023 | -5.20 |
| Dec 31, 2022 | -59.43 |
| Sep 30, 2022 | -71.82 |
| Jun 30, 2022 | -74.83 |
| Mar 31, 2022 | -81.94 |